Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: South Korea regulators unveil an accelerated pathway for innovative devices as part of an active week of medtech efforts; device execs sign on to letter seeking de-escalation in Minnesota; CMS seeks input on plans to increase purchasing of domestic PPE supplies; CDRH posts annual report; and medtech policy updates from FDA, Europe, China, and Malaysia.
Access to data and the use of it are increasingly important components of corporate strategy. How it is valued, structured and owned differentiates companies and raises challenges in dealmaking. A panel organized this month by Medtech Strategist for Weill Cornell Medicine’s BioVenture eLab Accelerator sought clarity, and an innovative, focused venture capitalist separately gives her firm’s creative investment thesis.
South Korean regulators have released multiple policies impacting medtech products, including a new fast-track market pathway. Excerpted from Pathways’ Picks January 28: South Korea Fast Track, Minnesota Letter, PPE Supply Ideas, and More.